Clinical Roundup Roswell Park study: Targeting the E3 ligase activity of MDM2 could help control p53 protein May 27, 2022Vol.48 No.21
Clinical Roundup OSUCCC-James study: Selective dopamine D2 receptor agonists may curb cancer growth, with fewer side effects May 27, 2022Vol.48 No.21
Clinical Roundup Yale study supports use of metabolic therapy in breast cancer May 27, 2022Vol.48 No.21
Clinical Roundup IU cancer researchers refine colorectal cancer classification, identify therapeutic targets May 27, 2022Vol.48 No.21
Clinical Roundup Cedars-Sinai Cancer study shows hormone therapy + pelvic lymph node treatment improves survival in prostate cancer May 27, 2022Vol.48 No.21
Clinical Roundup NCI study: Cancer death rates among Black people have declined, but disparities remain May 20, 2022Vol.48 No.20
Clinical Roundup ACS study: Medicaid expansion increases survival, reduces health disparities for newly diagnosed patients with cancer May 20, 2022Vol.48 No.20
Clinical Roundup MD Anderson study: Adolescent, young adult leukemia survivors have shorter life span than those who have never had cancer May 20, 2022Vol.48 No.20
Clinical Roundup Gabapentin is an effective alternative to opioids for cancer patients receiving radiation, Roswell Park team shows May 20, 2022Vol.48 No.20
Clinical Roundup Wilmot study: Polypharmacy presents risks for cancer patients undergoing therapy May 20, 2022Vol.48 No.20
